Royalty Pharma Reports Second Quarter 2025 Results

Go back to Royalty Pharma Reports Second Quarter 2025 Results
REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 60.58 -1.15 (1.86%)
Previous Close $61.73    52 Week High $3.48 
Open $61.33    52 Week Low $0.80 
Day High $62.13    P/E N/A 
Day Low $60.37    EPS $-1.54 
Volume 3,143,107